Insight Folios Inc Acquires 62 Shares of CME Group Inc. (NASDAQ:CME)

Insight Folios Inc raised its holdings in CME Group Inc. (NASDAQ:CME) by 4.0% in the 1st quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 1,612 shares of the financial services provider’s stock after purchasing an additional 62 shares during the quarter. Insight Folios Inc’s holdings in CME Group were worth $347,000 as of its most recent SEC filing.

Several other institutional investors have also recently bought and sold shares of CME. Gold Investment Management Ltd. bought a new position in CME Group in the 4th quarter valued at $26,000. Northwest Financial Advisors bought a new position in CME Group in the 4th quarter valued at $28,000. Harbor Investment Advisory LLC raised its position in CME Group by 966.7% in the 4th quarter. Harbor Investment Advisory LLC now owns 160 shares of the financial services provider’s stock valued at $34,000 after purchasing an additional 145 shares during the last quarter. BKM Wealth Management LLC bought a new position in CME Group in the 4th quarter valued at $38,000. Finally, Atticus Wealth Management LLC bought a new position in CME Group in the 3rd quarter valued at $40,000. Institutional investors own 87.75% of the company’s stock.

CME Group Trading Down 0.5 %

Shares of CME Group stock traded down $1.02 during trading on Thursday, reaching $196.06. 2,237,934 shares of the company were exchanged, compared to its average volume of 2,471,441. The company has a quick ratio of 1.01, a current ratio of 1.01 and a debt-to-equity ratio of 0.10. CME Group Inc. has a twelve month low of $180.11 and a twelve month high of $223.80. The business has a 50-day moving average price of $204.17 and a 200-day moving average price of $208.32. The firm has a market capitalization of $70.59 billion, a price-to-earnings ratio of 22.30, a P/E/G ratio of 5.20 and a beta of 0.52.

CME Group (NASDAQ:CME) last announced its quarterly earnings data on Wednesday, April 24th. The financial services provider reported $2.50 EPS for the quarter, topping analysts’ consensus estimates of $2.44 by $0.06. CME Group had a return on equity of 12.45% and a net margin of 56.84%. The business had revenue of $1.49 billion during the quarter, compared to analysts’ expectations of $1.48 billion. During the same period in the previous year, the firm earned $2.42 earnings per share. The firm’s quarterly revenue was up 3.2% compared to the same quarter last year. Sell-side analysts anticipate that CME Group Inc. will post 9.75 EPS for the current fiscal year.

CME Group Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Tuesday, June 25th. Investors of record on Friday, June 7th were paid a dividend of $1.15 per share. The ex-dividend date of this dividend was Friday, June 7th. This represents a $4.60 dividend on an annualized basis and a dividend yield of 2.35%. CME Group’s dividend payout ratio (DPR) is presently 52.33%.

Wall Street Analysts Forecast Growth

Several brokerages have issued reports on CME. Keefe, Bruyette & Woods reiterated a “market perform” rating and issued a $226.00 price objective on shares of CME Group in a research report on Wednesday. Deutsche Bank Aktiengesellschaft restated a “hold” rating and set a $210.00 target price (down previously from $235.00) on shares of CME Group in a research report on Friday, April 5th. Rosenblatt Securities restated a “sell” rating and set a $187.00 target price (up previously from $185.00) on shares of CME Group in a research report on Thursday, April 25th. Argus boosted their target price on CME Group from $225.00 to $245.00 and gave the stock a “buy” rating in a research report on Wednesday, March 6th. Finally, Morgan Stanley boosted their target price on CME Group from $222.00 to $225.00 and gave the stock an “equal weight” rating in a research report on Tuesday, April 9th. Three investment analysts have rated the stock with a sell rating, six have issued a hold rating and two have assigned a buy rating to the stock. Based on data from MarketBeat.com, the company currently has a consensus rating of “Hold” and a consensus target price of $215.90.

Insider Buying and Selling

In other CME Group news, Director Daniel R. Glickman sold 650 shares of the business’s stock in a transaction dated Thursday, June 6th. The stock was sold at an average price of $201.44, for a total value of $130,936.00. Following the completion of the transaction, the director now directly owns 14,008 shares of the company’s stock, valued at $2,821,771.52. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. In other CME Group news, Director Charles P. Carey sold 3,000 shares of the business’s stock in a transaction dated Thursday, June 13th. The stock was sold at an average price of $195.44, for a total value of $586,320.00. Following the completion of the transaction, the director now directly owns 7,163 shares of the company’s stock, valued at $1,399,936.72. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, Director Daniel R. Glickman sold 650 shares of the company’s stock in a transaction dated Thursday, June 6th. The stock was sold at an average price of $201.44, for a total value of $130,936.00. Following the transaction, the director now directly owns 14,008 shares of the company’s stock, valued at $2,821,771.52. The disclosure for this sale can be found here. Insiders sold a total of 54,290 shares of company stock valued at $11,393,700 over the last three months. Company insiders own 0.30% of the company’s stock.

CME Group Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.